/
ELMD
$42.23+$0.77 (+1.86%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$343.3M
8M shares
52-week range
$17.73 – $43.05
97% from low
Sector
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Exchange
XASE
CS
Borrow rate
0.41%
Easy to borrow
Price (6 mo)
Loading chart…
Change+$30.94
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $28.3M | $31.3M | $32.5M | $35.8M | $41.7M | $48.1M | $54.7M | $64.0M |
| Cost of revenue | $6.5M | $7.5M | $7.3M | $8.5M | $10.2M | $11.5M | $13.0M | $14.0M |
| Gross profit | $21.8M | $23.8M | $25.2M | $27.3M | $31.4M | $36.5M | $41.7M | $50.0M |
| Gross margin | 76.9% | 76.2% | 77.6% | 76.4% | 75.5% | 76.0% | 76.3% | 78.1% |
| R&D | $251.4K | $583.3K | $1.1M | $1.7M | $1.4M | $916.0K | $656.0K | $996.0K |
| Operating income | $2.7M | $2.8M | $5.1M | $3.1M | $3.0M | $4.0M | $6.6M | $9.9M |
| EBITDA | $3.5M | $3.8M | $5.9M | $3.8M | $3.6M | $4.7M | $7.9M | $11.5M |
| Net income | $1.8M | $2.0M | $4.2M | $2.4M | $2.3M | $3.2M | $5.2M | $7.5M |
| Net margin | 6.5% | 6.3% | 12.8% | 6.6% | 5.5% | 6.6% | 9.4% | 11.8% |
| EPS (diluted) | 0.22 | 0.23 | 0.47 | 0.27 | 0.26 | 0.36 | 0.58 | 0.86 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $74M | $1.22 | $1.21–$1.22 | 2 |
| 2027 | $84M | $1.48 | $1.47–$1.49 | 2 |
| 2028 | $92M | $1.77 | $1.76–$1.78 | 1 |
| 2029 | $82M | $1.09 | $1.08–$1.10 | 1 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$63.37
Price
$42.23
Implied upside
+50%
Peer comparison
Electromed, Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
www.smartvest.com- Employees
- 180
- IPO / List date
- Aug 13, 2010
- HQ
- NEW PRAGUE, MN
Held by traders on TradeandTell
No one on the platform currently holds ELMD.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 124,004 | $2.9M |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded ELMD yet.
